Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Page 1
The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?
Grover SA, Ho V, Lavoie F, Coupal L, Zowall H, Pilote L. Grover SA, et al. Among authors: zowall h. Arch Intern Med. 2003 Feb 10;163(3):333-9. doi: 10.1001/archinte.163.3.333. Arch Intern Med. 2003. PMID: 12578514
METHODS: We used the Cardiovascular Life Expectancy Model to estimate the long-term benefits and cost-effectiveness of lipid level modification with atorvastatin calcium, including 28% and 38% reductions in total cholesterol and low-density lipoprotein cholesterol levels, …
METHODS: We used the Cardiovascular Life Expectancy Model to estimate the long-term benefits and cost-effectiveness of lipid level mo …
How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?
Grover SA, Coupal L, Zowall H, Alexander CM, Weiss TW, Gomes DR. Grover SA, et al. Among authors: zowall h. Diabetes Care. 2001 Jan;24(1):45-50. doi: 10.2337/diacare.24.1.45. Diabetes Care. 2001. PMID: 11194239
OBJECTIVE: Epidemiological studies have shown that the risk of myocardial infarction (MI) in diabetic patients without cardiovascular disease (CVD) is comparable to the risk of MI in patients with CVD. We used a validated Markov model to compare the long-term costs and ben …
OBJECTIVE: Epidemiological studies have shown that the risk of myocardial infarction (MI) in diabetic patients without cardiovascular diseas …
Cost-effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated?
Grover SA, Coupal L, Zowall H, Dorais M. Grover SA, et al. Among authors: zowall h. Circulation. 2000 Aug 15;102(7):722-7. doi: 10.1161/01.cir.102.7.722. Circulation. 2000. PMID: 10942738
BACKGROUND: The objective of this study was to estimate the long-term costs and benefits of treating hyperlipidemia among diabetic patients with and without known cardiovascular disease after validating the Cardiovascular Life Expectancy Model. ...We forecasted the long- …
BACKGROUND: The objective of this study was to estimate the long-term costs and benefits of treating hyperlipidemia among diabetic pa …
The cost-effectiveness of exercise training for the primary and secondary prevention of cardiovascular disease.
Lowensteyn I, Coupal L, Zowall H, Grover SA. Lowensteyn I, et al. Among authors: zowall h. J Cardiopulm Rehabil. 2000 May-Jun;20(3):147-55. doi: 10.1097/00008483-200005000-00002. J Cardiopulm Rehabil. 2000. PMID: 10860196
BACKGROUND: Although exercise training improves cardiovascular disease (CVD) risk factors, few studies have evaluated its potential long-term cost-effectiveness. METHODS: Using the Cardiovascular Disease Life Expectancy Model, a validated disease simulation model, we calcu …
BACKGROUND: Although exercise training improves cardiovascular disease (CVD) risk factors, few studies have evaluated its potential long- …
Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis.
Clarke AE, Levinton C, Joseph L, Penrod J, Zowall H, Sibley JT, Grover SA, Esdaile JM. Clarke AE, et al. Among authors: zowall h. J Rheumatol. 1999 May;26(5):1068-75. J Rheumatol. 1999. PMID: 10332970
Regression models incorporating longitudinal data did not perform better than average costs in the preceding time period in predicting future short term costs. CONCLUSION: Global well being, pain, functional disability, and previous costs are the most important predictors …
Regression models incorporating longitudinal data did not perform better than average costs in the preceding time period in predicting futur …
Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events.
Grover SA, Coupal L, Paquet S, Zowall H. Grover SA, et al. Among authors: zowall h. Arch Intern Med. 1999 Mar 22;159(6):593-600. doi: 10.1001/archinte.159.6.593. Arch Intern Med. 1999. PMID: 10090116
OBJECTIVE: To forecast the long-term benefits and cost-effectiveness of lipid modification in the secondary prevention of cardiovascular disease. ...Assuming that lipid modification has no effect on the risk of stroke, cost-effectiveness increased by as much as 100%. CONCL …
OBJECTIVE: To forecast the long-term benefits and cost-effectiveness of lipid modification in the secondary prevention of cardiovascu …